| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Revenues: |
| Chemicals | 18.8 | 21.9 | 19.6 | 21.5 | 18.2 | 21.6 | 67.5 | 16.7 |
| Biofuels | 66.6 | 52.3 | 98.2 | 96.6 | 99.6 | 20.7 | 87.9 | 82.0 |
| Total revenues | 85.3 | 74.2 | 117.8 | 118.1 | 117.8 | 42.3 | 107.1 | 98.7 |
| Revenue growth [+] | -27.6% | 75.5% | 10.0% | 19.7% | 58.9% | 1.8% | 114.7% | 82.3% |
| Chemicals | 3.1% | 1.5% | -70.9% | 28.8% | 17.0% | 33.8% | 324.2% | 31.0% |
| Biofuels | -33.2% | 152.7% | 11.7% | 17.9% | 70.1% | -18.5% | 158.8% | 98.0% |
| Cost of goods sold | 93.9 | 52.6 | 102.6 | 98.2 | 116.8 | 49.4 | 80.9 | 90.5 |
| Gross profit | -8.6 | 21.6 | 15.2 | 20.0 | 1.0 | -7.2 | 26.1 | 8.2 |
| Gross margin | -10.1% | 29.1% | 12.9% | 16.9% | 0.8% | -16.9% | 24.4% | 8.3% |
| Selling, general and administrative [+] | 1.8 | 2.1 | 2.2 | 2.0 | 1.6 | 1.6 | 3.0 | 1.1 |
| General and administrative | 1.8 | 2.1 | 2.2 | 2.0 | 1.6 | 1.6 | 3.0 | 1.1 |
| Other selling, general and administrative | | | | | | | | |
| Research and development | 1.0 | 1.1 | 1.0 | 1.0 | 0.8 | 0.7 | 1.1 | 0.8 |
| Other operating expenses | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
| EBITDA [+] | -9.0 | 20.8 | 14.4 | 19.5 | 1.2 | -7.0 | 24.4 | 8.8 |
| EBITDA growth | -853.9% | -395.6% | -41.0% | 121.2% | 92.1% | -32.7% | 194.1% | 35.4% |
| EBITDA margin | -10.5% | 28.0% | 12.2% | 16.5% | 1.0% | -16.7% | 22.8% | 8.9% |
| Depreciation and amortization | 2.6 | 2.6 | 2.6 | 2.6 | 2.7 | 2.6 | 2.6 | 2.7 |
| EBIT [+] | -11.6 | 18.3 | 11.8 | 16.9 | -1.5 | -9.6 | 21.8 | 6.1 |
| EBIT growth | 664.6% | -290.0% | -46.0% | 175.0% | -24.4% | -26.4% | 283.1% | 61.5% |
| EBIT margin | -13.6% | 24.6% | 10.0% | 14.3% | -1.3% | -22.7% | 20.4% | 6.2% |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Other income (expense), net [+] | 1.8 | 2.9 | 1.7 | 0.6 | -2.5 | -3.5 | 2.3 | -0.1 |
| Unrealized gain (loss) on marketable securities | 0.0 | 0.5 | -0.6 | -0.6 | -3.2 | -4.1 | 0.1 | -0.7 |
| Other | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | | 1.5 | 0.0 |
| Pre-tax income | -9.8 | 21.1 | 13.4 | 17.5 | -4.0 | -13.1 | 24.1 | 6.0 |
| Income taxes | 0.0 | 0.0 | -1.5 | 1.7 | -0.9 | -0.7 | 1.7 | -3.2 |
| Tax rate | | 0.0% | | 9.7% | 23.2% | 5.4% | 7.1% | |
| Net income | -9.9 | 21.1 | 14.9 | 15.8 | -3.1 | -12.4 | 22.3 | 9.2 |
| Net margin | -11.6% | 28.4% | 12.7% | 13.4% | -2.6% | -29.3% | 20.9% | 9.3% |
| |
| Basic EPS [+] | ($0.23) | $0.48 | $0.34 | $0.36 | ($0.07) | ($0.28) | $0.51 | $0.21 |
| Growth | 217.6% | -270.0% | -33.2% | 71.5% | -189.2% | 41.3% | 308.2% | 33.5% |
| Diluted EPS [+] | ($0.23) | $0.48 | $0.34 | $0.36 | ($0.07) | ($0.28) | $0.51 | $0.21 |
| Growth | 217.6% | -270.0% | -33.2% | 71.5% | -189.2% | 41.3% | 308.2% | 33.5% |
| |
| Dividends per share [+] | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 | $0.06 |
| Growth | 0.0% | 0.0% | 0.1% | 0.0% | -97.7% | 0.0% | -0.1% | 0.0% |
| |
| Shares outstanding (basic) [+] | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 |
| Growth | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Shares outstanding (diluted) [+] | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 | 43.8 |
| Growth | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |